Morphine metabolism in neonates and infants

Area of Science:

• Pharmacology
• Neonatal Medicine
• Drug Metabolism

Background:

• Morphine is commonly used for pain relief in neonates.
• Understanding morphine metabolism is crucial for safe and effective neonatal pain management.
• Previous studies have indicated differences in drug metabolism between neonatal and pediatric populations.

Purpose of the Study:

• To investigate the pharmacokinetic profile of morphine in full-term neonates and infants.
• To quantify plasma concentrations of morphine and its primary metabolites, morphine 3-glucuronide (M3G) and morphine 6-glucuronide (M6G).
• To compare morphine metabolism in full-term neonates with previously reported data for preterm neonates and children.

Main Methods:

• Continuous infusion of morphine was administered to seven full-term neonates and five infants.
• Plasma concentrations of morphine, M3G, and M6G were measured.
• Plasma clearance of morphine was calculated.
• M3G/morphine ratios were determined and compared across different age groups.

Main Results:

• All patients exhibited detectable plasma concentrations of M3G and M6G.
• The mean plasma clearance of morphine was 20.1 ml min-1 kg-1 in neonates.
• The M3G/morphine ratio in full-term neonates (7.3) was higher than in preterm neonates (5.0) but lower than in children (23.9).

Conclusions:

• Full-term neonates metabolize morphine differently than preterm neonates and children, with a distinct M3G/morphine ratio.
• These findings highlight the importance of age-specific pharmacokinetic considerations for morphine therapy in neonates.
• Further research may be warranted to explore the clinical implications of these metabolic differences.